SpringWorks Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Operating Revenue	200.12	172.04	5.45	-	-	35	Upgrade
Other Revenue	19.55	19.55	-	-	-	-	Upgrade
Revenue	219.67	191.59	5.45	-	-	35	Upgrade
Revenue Growth (YoY)	730.42%	3417.33%	-	-	-	-	Upgrade
Cost of Revenue	14.88	12.55	0.42	-	-	-	Upgrade
Gross Profit	204.8	179.04	5.03	-	-	35	Upgrade
Selling, General & Admin	273.04	256.65	197.55	134.55	71.79	29.47	Upgrade
Research & Development	196.49	200.52	150.49	146.12	101.68	51.86	Upgrade
Operating Expenses	469.53	457.17	348.04	280.67	173.47	81.32	Upgrade
Operating Income	-264.74	-278.13	-343.01	-280.67	-173.47	-46.32	Upgrade
Interest & Investment Income	18.43	26	22.95	6.15	0.55	1.33	Upgrade
Earnings From Equity Investments	-6.63	-6	-5.04	-2.89	-0.99	-0.61	Upgrade
Other Non Operating Income (Expenses)	-	-	-	-	-	0.03	Upgrade
Pretax Income	-253.93	-258.13	-325.1	-277.42	-173.91	-45.57	Upgrade
Net Income	-253.93	-258.13	-325.1	-277.42	-173.91	-45.57	Upgrade
Net Income to Common	-253.93	-258.13	-325.1	-277.42	-173.91	-45.57	Upgrade
Shares Outstanding (Basic)	74	74	63	53	48	43	Upgrade
Shares Outstanding (Diluted)	74	74	63	53	48	43	Upgrade
Shares Change (YoY)	12.77%	17.44%	18.45%	9.88%	12.00%	226.18%	Upgrade
EPS (Basic)	-3.41	-3.48	-5.15	-5.21	-3.59	-1.05	Upgrade
EPS (Diluted)	-3.41	-3.48	-5.15	-5.21	-3.59	-1.05	Upgrade
Free Cash Flow	-169.33	-180.05	-230.18	-171.76	-129.89	-32.83	Upgrade
Free Cash Flow Per Share	-2.28	-2.43	-3.65	-3.22	-2.68	-0.76	Upgrade
Gross Margin	93.23%	93.45%	92.25%	-	-	100.00%	Upgrade
Operating Margin	-120.52%	-145.17%	-6297.28%	-	-	-132.35%	Upgrade
Profit Margin	-115.60%	-134.73%	-5968.50%	-	-	-130.21%	Upgrade
Free Cash Flow Margin	-77.09%	-93.98%	-4225.81%	-	-	-93.81%	Upgrade
EBITDA	-260.9	-274.66	-341.35	-279.91	-172.98	-45.98	Upgrade
EBITDA Margin	-118.77%	-143.36%	-	-	-	-131.36%	Upgrade
D&A For EBITDA	3.84	3.47	1.67	0.77	0.49	0.35	Upgrade
EBIT	-264.74	-278.13	-343.01	-280.67	-173.47	-46.32	Upgrade
EBIT Margin	-120.52%	-145.17%	-	-	-	-132.35%	Upgrade
Revenue as Reported	219.67	191.59	5.45	-	-	-	Upgrade

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q